Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cytek Biosciences Inc
(NQ:
CTKB
)
6.380
+0.230 (+3.74%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytek Biosciences Inc
< Previous
1
2
3
4
Next >
Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
February 07, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
February 07, 2023
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Participate in Upcoming Investor Conferences
February 06, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Earnings Perspective: Return On Capital Employed
December 15, 2022
Via
Benzinga
Recap: Cytek Biosciences Q2 Earnings
August 10, 2022
Cytek Biosciences (NASDAQ:CTKB) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:03 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Preview: Cytek Biosciences
August 09, 2022
Cytek Biosciences (NASDAQ:CTKB) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.
Via
Benzinga
Oak Street Health, PriceSmart And Some Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
January 10, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More
December 15, 2022
The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference
November 21, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Introduces Cytek Cloud
November 15, 2022
New Digital Ecosystem Supports Full Spectrum Flow Cytometry Research – from Panel Design to Data Acquisition
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Where Cytek Biosciences Stands With Analysts
July 14, 2022
Cytek Biosciences (NASDAQ:CTKB) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Earnings Scheduled For May 11, 2022
May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Via
Benzinga
Cytek Biosciences Reports Third Quarter 2022 Financial Results
November 09, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Earnings Outlook For Cytek Biosciences
November 08, 2022
Cytek Biosciences (NASDAQ:CTKB) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Cytek...
Via
Benzinga
Cytek® Biosciences Names Chris Williams Chief Operating Officer
October 31, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
October 26, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek to Participate in the 31st Annual Credit Suisse Healthcare Conference
October 26, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Pinterest, Perion Network And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
October 06, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Piper Sandler Maintains Overweight Rating for Cytek Biosciences: Here's What You Need To Know
August 18, 2022
Piper Sandler has decided to maintain its Overweight rating of Cytek Biosciences (NASDAQ:CTKB) and raise its price target from $12.00 to $16.00. Shares of Cytek Biosciences are trading down 0.21%...
Via
Benzinga
Analyst Ratings for Cytek Biosciences
August 12, 2022
Over the past 3 months, 4 analysts have published their opinion on Cytek Biosciences (NASDAQ:CTKB) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Analyst Ratings for Cytek Biosciences
May 13, 2022
Over the past 3 months, 4 analysts have published their opinion on Cytek Biosciences (NASDAQ:CTKB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...
Via
Benzinga
74 Biggest Movers From Yesterday
June 03, 2022
Gainers
Via
Benzinga
Goldman Sachs Maintains Buy Rating for Cytek Biosciences: Here's What You Need To Know
May 12, 2022
Goldman Sachs has decided to maintain its Buy rating of Cytek Biosciences (NASDAQ:CTKB) and lower its price target from $14.00 to $12.00. Shares of Cytek Biosciences are trading up 10.93% over the last...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 21, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 23, 2022
On Wednesday, 63 companies set new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low was...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 24, 2022
On Thursday, 112 stocks made new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: Stanley Black & Decker (NYSE:SWK) was the largest firm by market...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
March 21, 2022
During Monday's session, 39 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company in terms of market cap to set a...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
March 18, 2022
During Friday's session, 24 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: TFS Financial (NASDAQ:TFSL) was the biggest company on a...
Via
Benzinga
Executives Buy More Than $1B Of 4 Stocks
March 17, 2022
Although US stock futures traded lower this morning on Thursday, there were a few notable insider trades.
Via
Benzinga
Dow And 3 Other Stocks Bought By Insiders
March 09, 2022
Although US stocks closed lower on Tuesday amid the ongoing Russia-Ukraine tensions, there were a few notable insider trades.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.